Japan Pemetrexed Market (2025-2031) | Pricing Analysis, Drivers, Strategic Insights, Share, Demand, Trends, Investment Trends, Size, Strategy, Segments, Growth, Companies, Outlook, Competition, Analysis, Competitive, Forecast, Value, Opportunities, Industry, Supply, Segmentation, Challenges, Revenue, Restraints, Consumer Insights

Market Forecast By Indication (Non-Small Cell Lung Cancer, Mesothelioma, Breast Cancer, Colorectal Cancer, Pancreatic Cancer), By Mechanism of Action (Antifolate, DNA Synthesis Inhibition, Enzyme Targeting, Cell Growth Suppression, Purine Synthesis Blockade), By Combination Therapy (Platinum-Based Chemotherapy, Immunotherapy, Radiation Therapy, Personalized Medicine, Monoclonal Antibodies), By End User (Hospitals, Oncology Clinics, Specialty Clinics, Research Institutes, Pharmaceutical Companies), By Administration Route (Intravenous, Injection, IV Infusion, Cancer Treatment Centers, Hospital Pharmacy) And Competitive Landscape
Product Code: ETC10765522 Publication Date: Apr 2025 Updated Date: Oct 2025 Product Type: Market Research Report
Publisher: 6Wresearch No. of Pages: 65 No. of Figures: 34 No. of Tables: 19

Japan Pemetrexed Market Import Shipment by Countries (Top 5) & Competition (HHI)

The Japan pemetrexed import market in 2024 continued to see a diverse range of sources, with top exporting countries being the USA, Germany, Ireland, Switzerland, and Sweden. Despite the variety of sources, market concentration, as measured by the Herfindahl-Hirschman Index (HHI), remained low. The market experienced a slight decline over the period 2020-2024, with a compound annual growth rate (CAGR) of -3.23%. The growth rate from 2023 to 2024 also showed a decrease of -2.99%, indicating a challenging environment for pemetrexed imports in Japan.

Japan Pemetrexed Market Import Shipment by Countries (Top 5) & Competition (HHI)

Key Highlights of the Report:

  • Japan Pemetrexed Market Outlook
  • Market Size of Japan Pemetrexed Market,2024
  • Forecast of Japan Pemetrexed Market, 2031
  • Historical Data and Forecast of Japan Pemetrexed Revenues & Volume for the Period 2021-2031
  • Japan Pemetrexed Market Trend Evolution
  • Japan Pemetrexed Market Drivers and Challenges
  • Japan Pemetrexed Price Trends
  • Japan Pemetrexed Porter's Five Forces
  • Japan Pemetrexed Industry Life Cycle
  • Historical Data and Forecast of Japan Pemetrexed Market Revenues & Volume By Indication for the Period 2021-2031
  • Historical Data and Forecast of Japan Pemetrexed Market Revenues & Volume By Non-Small Cell Lung Cancer for the Period 2021-2031
  • Historical Data and Forecast of Japan Pemetrexed Market Revenues & Volume By Mesothelioma for the Period 2021-2031
  • Historical Data and Forecast of Japan Pemetrexed Market Revenues & Volume By Breast Cancer for the Period 2021-2031
  • Historical Data and Forecast of Japan Pemetrexed Market Revenues & Volume By Colorectal Cancer for the Period 2021-2031
  • Historical Data and Forecast of Japan Pemetrexed Market Revenues & Volume By Pancreatic Cancer for the Period 2021 - 2029
  • Historical Data and Forecast of Japan Pemetrexed Market Revenues & Volume By Mechanism of Action for the Period 2021-2031
  • Historical Data and Forecast of Japan Pemetrexed Market Revenues & Volume By Antifolate for the Period 2021-2031
  • Historical Data and Forecast of Japan Pemetrexed Market Revenues & Volume By DNA Synthesis Inhibition for the Period 2021-2031
  • Historical Data and Forecast of Japan Pemetrexed Market Revenues & Volume By Enzyme Targeting for the Period 2021-2031
  • Historical Data and Forecast of Japan Pemetrexed Market Revenues & Volume By Cell Growth Suppression for the Period 2021-2031
  • Historical Data and Forecast of Japan Pemetrexed Market Revenues & Volume By Purine Synthesis Blockade for the Period 2021 - 2029
  • Historical Data and Forecast of Japan Pemetrexed Market Revenues & Volume By Combination Therapy for the Period 2021-2031
  • Historical Data and Forecast of Japan Pemetrexed Market Revenues & Volume By Platinum-Based Chemotherapy for the Period 2021-2031
  • Historical Data and Forecast of Japan Pemetrexed Market Revenues & Volume By Immunotherapy for the Period 2021-2031
  • Historical Data and Forecast of Japan Pemetrexed Market Revenues & Volume By Radiation Therapy for the Period 2021-2031
  • Historical Data and Forecast of Japan Pemetrexed Market Revenues & Volume By Personalized Medicine for the Period 2021-2031
  • Historical Data and Forecast of Japan Pemetrexed Market Revenues & Volume By Monoclonal Antibodies for the Period 2021 - 2029
  • Historical Data and Forecast of Japan Pemetrexed Market Revenues & Volume By End User for the Period 2021-2031
  • Historical Data and Forecast of Japan Pemetrexed Market Revenues & Volume By Hospitals for the Period 2021-2031
  • Historical Data and Forecast of Japan Pemetrexed Market Revenues & Volume By Oncology Clinics for the Period 2021-2031
  • Historical Data and Forecast of Japan Pemetrexed Market Revenues & Volume By Specialty Clinics for the Period 2021-2031
  • Historical Data and Forecast of Japan Pemetrexed Market Revenues & Volume By Research Institutes for the Period 2021-2031
  • Historical Data and Forecast of Japan Pemetrexed Market Revenues & Volume By Pharmaceutical Companies for the Period 2021 - 2029
  • Historical Data and Forecast of Japan Pemetrexed Market Revenues & Volume By Administration Route for the Period 2021-2031
  • Historical Data and Forecast of Japan Pemetrexed Market Revenues & Volume By Intravenous for the Period 2021-2031
  • Historical Data and Forecast of Japan Pemetrexed Market Revenues & Volume By Injection for the Period 2021-2031
  • Historical Data and Forecast of Japan Pemetrexed Market Revenues & Volume By IV Infusion for the Period 2021-2031
  • Historical Data and Forecast of Japan Pemetrexed Market Revenues & Volume By Cancer Treatment Centers for the Period 2021 - 2029
  • Historical Data and Forecast of Japan Pemetrexed Market Revenues & Volume By Hospital Pharmacy for the Period 2021 - 2029
  • Japan Pemetrexed Import Export Trade Statistics
  • Market Opportunity Assessment By Indication
  • Market Opportunity Assessment By Mechanism of Action
  • Market Opportunity Assessment By Combination Therapy
  • Market Opportunity Assessment By End User
  • Market Opportunity Assessment By Administration Route
  • Japan Pemetrexed Top Companies Market Share
  • Japan Pemetrexed Competitive Benchmarking By Technical and Operational Parameters
  • Japan Pemetrexed Company Profiles
  • Japan Pemetrexed Key Strategic Recommendations

Frequently Asked Questions About the Market Study (FAQs):

6Wresearch actively monitors the Japan Pemetrexed Market and publishes its comprehensive annual report, highlighting emerging trends, growth drivers, revenue analysis, and forecast outlook. Our insights help businesses to make data-backed strategic decisions with ongoing market dynamics. Our analysts track relevent industries related to the Japan Pemetrexed Market, allowing our clients with actionable intelligence and reliable forecasts tailored to emerging regional needs.
Yes, we provide customisation as per your requirements. To learn more, feel free to contact us on sales@6wresearch.com

1 Executive Summary

2 Introduction

2.1 Key Highlights of the Report

2.2 Report Description

2.3 Market Scope & Segmentation

2.4 Research Methodology

2.5 Assumptions

3 Japan Pemetrexed Market Overview

3.1 Japan Country Macro Economic Indicators

3.2 Japan Pemetrexed Market Revenues & Volume, 2021 & 2031F

3.3 Japan Pemetrexed Market - Industry Life Cycle

3.4 Japan Pemetrexed Market - Porter's Five Forces

3.5 Japan Pemetrexed Market Revenues & Volume Share, By Indication, 2021 & 2031F

3.6 Japan Pemetrexed Market Revenues & Volume Share, By Mechanism of Action, 2021 & 2031F

3.7 Japan Pemetrexed Market Revenues & Volume Share, By Combination Therapy, 2021 & 2031F

3.8 Japan Pemetrexed Market Revenues & Volume Share, By End User, 2021 & 2031F

3.9 Japan Pemetrexed Market Revenues & Volume Share, By Administration Route, 2021 & 2031F

4 Japan Pemetrexed Market Dynamics

4.1 Impact Analysis

4.2 Market Drivers

4.2.1 Increasing prevalence of lung cancer in Japan

4.2.2 Growing awareness about the benefits of pemetrexed in cancer treatment

4.2.3 Advancements in healthcare infrastructure and access to cancer care services in Japan

4.3 Market Restraints

4.3.1 Stringent regulatory requirements for drug approvals in Japan

4.3.2 High cost associated with pemetrexed treatment

4.3.3 Competition from alternative cancer treatment options

5 Japan Pemetrexed Market Trends

6 Japan Pemetrexed Market, By Types

6.1 Japan Pemetrexed Market, By Indication

6.1.1 Overview and Analysis

6.1.2 Japan Pemetrexed Market Revenues & Volume, By Indication, 2021 - 2031F

6.1.3 Japan Pemetrexed Market Revenues & Volume, By Non-Small Cell Lung Cancer, 2021 - 2031F

6.1.4 Japan Pemetrexed Market Revenues & Volume, By Mesothelioma, 2021 - 2031F

6.1.5 Japan Pemetrexed Market Revenues & Volume, By Breast Cancer, 2021 - 2031F

6.1.6 Japan Pemetrexed Market Revenues & Volume, By Colorectal Cancer, 2021 - 2031F

6.1.7 Japan Pemetrexed Market Revenues & Volume, By Pancreatic Cancer, 2021 - 2031F

6.2 Japan Pemetrexed Market, By Mechanism of Action

6.2.1 Overview and Analysis

6.2.2 Japan Pemetrexed Market Revenues & Volume, By Antifolate, 2021 - 2031F

6.2.3 Japan Pemetrexed Market Revenues & Volume, By DNA Synthesis Inhibition, 2021 - 2031F

6.2.4 Japan Pemetrexed Market Revenues & Volume, By Enzyme Targeting, 2021 - 2031F

6.2.5 Japan Pemetrexed Market Revenues & Volume, By Cell Growth Suppression, 2021 - 2031F

6.2.6 Japan Pemetrexed Market Revenues & Volume, By Purine Synthesis Blockade, 2021 - 2031F

6.3 Japan Pemetrexed Market, By Combination Therapy

6.3.1 Overview and Analysis

6.3.2 Japan Pemetrexed Market Revenues & Volume, By Platinum-Based Chemotherapy, 2021 - 2031F

6.3.3 Japan Pemetrexed Market Revenues & Volume, By Immunotherapy, 2021 - 2031F

6.3.4 Japan Pemetrexed Market Revenues & Volume, By Radiation Therapy, 2021 - 2031F

6.3.5 Japan Pemetrexed Market Revenues & Volume, By Personalized Medicine, 2021 - 2031F

6.3.6 Japan Pemetrexed Market Revenues & Volume, By Monoclonal Antibodies, 2021 - 2031F

6.4 Japan Pemetrexed Market, By End User

6.4.1 Overview and Analysis

6.4.2 Japan Pemetrexed Market Revenues & Volume, By Hospitals, 2021 - 2031F

6.4.3 Japan Pemetrexed Market Revenues & Volume, By Oncology Clinics, 2021 - 2031F

6.4.4 Japan Pemetrexed Market Revenues & Volume, By Specialty Clinics, 2021 - 2031F

6.4.5 Japan Pemetrexed Market Revenues & Volume, By Research Institutes, 2021 - 2031F

6.4.6 Japan Pemetrexed Market Revenues & Volume, By Pharmaceutical Companies, 2021 - 2031F

6.5 Japan Pemetrexed Market, By Administration Route

6.5.1 Overview and Analysis

6.5.2 Japan Pemetrexed Market Revenues & Volume, By Intravenous, 2021 - 2031F

6.5.3 Japan Pemetrexed Market Revenues & Volume, By Injection, 2021 - 2031F

6.5.4 Japan Pemetrexed Market Revenues & Volume, By IV Infusion, 2021 - 2031F

6.5.5 Japan Pemetrexed Market Revenues & Volume, By Cancer Treatment Centers, 2021 - 2031F

6.5.6 Japan Pemetrexed Market Revenues & Volume, By Hospital Pharmacy, 2021 - 2031F

7 Japan Pemetrexed Market Import-Export Trade Statistics

7.1 Japan Pemetrexed Market Export to Major Countries

7.2 Japan Pemetrexed Market Imports from Major Countries

8 Japan Pemetrexed Market Key Performance Indicators

8.1 Number of clinical trials using pemetrexed in Japan

8.2 Adoption rate of pemetrexed in different regions of Japan

8.3 Patient satisfaction and outcomes post pemetrexed treatment

9 Japan Pemetrexed Market - Opportunity Assessment

9.1 Japan Pemetrexed Market Opportunity Assessment, By Indication, 2021 & 2031F

9.2 Japan Pemetrexed Market Opportunity Assessment, By Mechanism of Action, 2021 & 2031F

9.3 Japan Pemetrexed Market Opportunity Assessment, By Combination Therapy, 2021 & 2031F

9.4 Japan Pemetrexed Market Opportunity Assessment, By End User, 2021 & 2031F

9.5 Japan Pemetrexed Market Opportunity Assessment, By Administration Route, 2021 & 2031F

10 Japan Pemetrexed Market - Competitive Landscape

10.1 Japan Pemetrexed Market Revenue Share, By Companies, 2024

10.2 Japan Pemetrexed Market Competitive Benchmarking, By Operating and Technical Parameters

11 Company Profiles

12 Recommendations

13 Disclaimer

Export potential assessment - trade Analytics for 2030

Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.

By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.

To discover high-growth global markets and optimize your business strategy:

Click Here
Pricing
  • Single User License
    $ 1,995
  • Department License
    $ 2,400
  • Site License
    $ 3,120
  • Global License
    $ 3,795
6Wresearch Support

Any Query

Call: +91-11-4302-4305
Email us: sales@6wresearch.com
Any Query? Click Here

Thought Leadership and Analyst Meet

Our Clients

Airtel
Canon
Contec
HoneyWell
Kriloskar
Pwc Logo
Samsung
Tata Teleservices

Related Reports

Industry Events and Analyst Meet

Whitepaper

Read All
Chat With 6W AI Intelligence